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Australo-papuan death adders (Acanthophis spp.) are a cause of serious 
envenomations in Papua New Guinea and northern Australia often resulting in 
neurotoxic paralysis. Furthermore, victims occasionally present with delayed-onset 
neurotoxicity that sometimes responds poorly to antivenom or anticholinesterase 
treatment. This clinical outcome could be explained by the presence of potent snake 
presynaptic phospholipase A2 neurotoxin (SPAN) complexes and monomers, in addition 
to long- and short-chain postsynaptic α-neurotoxins, that bind irreversibly, block 
neurotransmitter release and result in degeneration of the nerve terminal. The present 
study therefore aimed to determine within-genus variations in expression of high 
molecular mass SPAN complexes in the venoms of six major species of Acanthophis, 
four geographic variants of A. antarcticus. Venoms were separated by size-exclusion 
liquid chromatography under non-denaturing conditions and fractions corresponding to 
proteins in the range of 22 to >60 kDa were subjected to pharmacological 
characterisation using the isolated chick biventer cervicis nerve-muscle (CBCNM) 
preparation. All venoms, except A. wellsi and A. pyrrhus, contained high mass fractions 
with phospholipase A2 activity that inhibited twitch contractions of the CBCNM 
preparation. This inhibition was of slow onset, and responses to exogenous nicotinic 
agonists were not blocked, consistent with the presence of SPAN complexes. The 
results of the present study indicate that clinicians may need to be aware of possible 
prejunctional neurotoxicity following envenomations from A. antarcticus (all geographic 
variants except perhaps South Australia), A. praelongus, A. rugosus and A. laevis 
species, and that early antivenom intervention is important in preventing further 
development of toxicity. 
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The family Elapidae consists of a variety of highly venomous snake genera, including 
the death adders (Acanthophis spp.), which are considered elapids despite their viper-
like appearance and behaviour. In addition, death adders have semi-mobile fangs which 
results in them being commonly regarded as the most evolved of all elapids and 
morphologically transitional between the Elapidae and Viperidae. Indeed, death adders 
are the widest ranging of the Australian elapids with a variety of species found 
throughout continental Australia, Irian Jaya, Papua New Guinea (PNG) and some 
eastern Indonesian islands including the Maluku islands of Seram (formerly Ceram), 
Halmahera, Obi and Tanimbar (Lalloo et al., 1996; Wüster et al., 2005). This wide range 
and ecological specialization of Acanthophis is consistent with its relatively early 
divergence from its closest sister lineage around 9.1 Mya (Sanders et al., 2008).  
Acanthophis species are the second most common cause of envenomation in the 
Central Province and National Capital District of PNG, second only to the Papuan taipan 
(Oxyuranus scutellatus canni). They have been reported to be responsible for ca. 11% 
of patients admitted for envenomation in these areas between January 1990 and June 
1992 (Lalloo et al., 1994). The death adder has additionally been reported to be the 
cause of most serious envenomations in the Madang region of PNG (Hudson and 
Pomat, 1988) while in northern Australia death adder envenomation is also considered 
a serious problem (Currie, 2003). General symptoms of envenomation from 
Acanthophis species can include pain in regional lymph nodes, and non-specific 
systemic features such as abdominal pain, headache, drowsiness, nausea and 
vomiting. More problematic are neurological symptoms that typically involve ptosis, 
dysarthria, dysphagia, diplopia and flaccid muscle paralysis with death resulting from 
respiratory failure (Campbell, 1966; Lalloo et al., 1996). Myotoxicity is not usually 
associated with envenomation but there are clinical reports in PNG of rhabdomyolysis 
with A. rugosus (Lalloo et al., 1996). Significantly, delayed-onset neurotoxicity is a 
problem in death adder envenomations, occasionally with late presentation of 
neurotoxicity as the first feature of envenoming (Currie, 1989; Currie, 2003; Lalloo et al., 
1996). This has resulted in a recommended hospital admission period of 24 hours for 
B. Blacklow et al. / Toxicon 
	  
5	  
patients in PNG and both central and northern Australia, and for children in any region 
(Currie, 2006). 
The primary treatment for death adder envenomation is CSL monovalent death adder 
antivenom, which has been raised against A. antarcticus (White, 1998; White, 2001). 
Death adder antivenom appears to be quite effective in preventing the progression of 
neurotoxicity from all species of death adder in Australia and PNG (Campbell, 1966; 
Lalloo et al., 1996), showing a rapid reversal of paralysis. However, conflicting reports 
with Australian death adder envenomation have suggested that the neurotoxic effects 
can be poorly reversed by antivenom or anticholinesterase (neostigmine) if the patient 
presents late after envenomation (Gunja et al., 2007). In support, an in vitro study 
involving A. antarcticus, A. praelongus and A. pyrrhus venoms found that all three 
venoms produced rapid postsynaptic neurotoxicity but antivenom displayed varying 
efficacy to reverse toxicity following neuromuscular blockade over a 4 hour period. 
Indeed, there was only a 22% recovery of contractile responses following complete 
neuromuscular blockade with A. antarcticus, the venom to which the antivenom is 
raised (Wickramaratna and Hodgson, 2001).  
It is commonly regarded that death adder neurotoxicity is mainly postsynaptic in origin, 
and therefore this suggests that the postsynaptic neurotoxins (so-called ‘α-’ or ‘three-
fingered’ neurotoxins) present within death adder venoms may not be completely 
reversible or are ‘pseudo-irreversible’. However, rapidly developing neurotoxicity from 
postsynaptic neurotoxins conceals the action of any underlying presynaptic neurotoxins 
or myotoxins that may be present in the venom, which typically have slower onsets of 
activity but bind irreversibly (Kelly and Brown, 1974; Wilson et al., 1995). In the case of 
patients with delayed-onset or slowly-developing neurotoxicity, presynaptic neurotoxins 
or myotoxins may play a significant role in the speed of recovery following antivenom 
therapy due to the irreversible nature of their actions, and may go some way to explain 
the above resistance to antivenom therapy. The presence of myotoxins in the venom of 
A. praelongus, A. rugosus, A. sp. Seram, and A. wellsi species has been previously 
determined (Hart et al., 2005; Wickramaratna et al., 2003a; Wickramaratna et al., 
2003b) and rhabdomyolysis has been reported clinically with A. rugosus envenomation 
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(Lalloo et al., 1996). However, this does not exclude the presence of presynaptic 
neurotoxins in these venoms, or in other major species or geographic variants of A. 
antarcticus. 
It is therefore possible that Acanthophis venoms contain snake presynaptic 
phospholipase A2 (PLA2) neurotoxins (so-called ‘β-neurotoxins’ or SPANs) that bind 
irreversibly to motor nerve terminals (Rossetto and Montecucco, 2008). In support, 
highly toxic heteromultimeric SPANs have been identified and pharmacologically 
characterized from the venom of a number of other Australo-Papuan elapid snake 
venoms, including, paradoxin (inland taipan, Oxyuranus microlepidotus; (Fohlman, 
1979; Hodgson et al., 2007), taipoxin (coastal taipan, O. scutellatus; (Fohlman et al., 
1976), cannitoxin (Papuan taipan, O. scutellatus canni; (Kuruppu et al., 2005b) and 
textilotoxin (common brown snake, Pseudonaja textilis; (Su et al., 1983; Wilson et al., 
1995) and the monomeric notexin (tiger snake, Notechis s. scutatus; (Cull-Candy et al., 
1976). These are potent presynaptically-active neurotoxins with an LD50 of 1–25 µg/kg 
(mouse i.v. or i.p.). Furthermore, a protein from A. antarcticus venom with significant N-
terminal sequence homology to the γ-chain of the heterotrimeric SPAN taipoxin has 
been previously reported (Fry et al., 2002), suggestive of the presence of a SPAN in 
Acanthophis venom. 
SPANs can cause irreversible neurotoxicity via the depletion of neurotransmitter, due to 
a modest increase in transmitter release and a block of vesicle recycling, as well as the 
degeneration of motor nerve terminals and intramuscular axons (Harris et al., 2000). 
Regeneration and functional reinnervation can take several days (Dixon and Harris, 
1999; Harris et al., 2000) and in humans paralysis resulting from SPANs not promptly 
treated with antivenom can last many days. Some patients even require artificial 
ventilation and, in isolated cases, intensive care for prolonged periods (Connolly et al., 
1995; Pearn, 1971; Trevett et al., 1995). While a number of monomeric PLA2 proteins 
have been isolated from death adder venom (Chow et al., 1998; Sim, 1998; van der 
Weyden et al., 2000; van der Weyden et al., 1997), none of these have been 
characterized pharmacologically and there have be no previous reports of attempts at 
isolating multimeric SPAN complexes in the venom of Acanthophis spp.  
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Given the high potency of SPAN complexes from other Australian elapid venoms, the 
aim of this study was to determine whether the venoms of various species and 
geographic variants of Australian death adders also contain SPAN complexes. The 
presence of such components could explain reports of poorly reversible neurotoxicity in 
post-envenomated patients not treated promptly with antivenom. 
 
2. Materials and methods 
2.1. Venom source and storage 
Lyophilized pooled Acanthophis spp. venoms were provided by Venom Supplies 
(Tanunda, South Australia). The death adders were collected from their natural habitats 
in Australia and PNG. A degree of controversy exists regarding the taxonomy of the 
death adders (Williams et al., 2006; Wüster et al., 2005; Wüster et al., 1999), with as 
many as 15 separate species reported by various sources. Therefore, reporting the 
locations of Acanthophis snakes used in this study is crucial to allow any subsequent 
interpretation of these results in the light of any future revision of the taxonomy of 
Acanthophis. Presently the common death adder, A. antarcticus, is the widest ranging 
species found in the coastal areas of Australia with two disjoint geographic ranges, New 
South Wales (NSW)/Queensland (QLD) and South Australia (SA)/Western Australia 
(WA). Venom was obtained from populations in Sydney (A. antarcticus NSW), Mt 
Glorious northwest of Brisbane (A. antarcticus QLD), Middleback Ranges close to 
Whyalla (A. antarcticus SA), and Darling Range (A. antarcticus WA). Other Acanthophis 
spp. included in this study are the northern death adder A. praelongus (sourced from 
Cairns, QLD), desert death adder A. pyrrhus (north of Alice Springs, Northern Territory), 
as well as the Pilbara death adder A. wellsi (Pilbarra, WA). The rough-scaled A. rugosus 
(sourced from Merauke, West Papua, Indonesia) and smooth-scaled A. laevis (Seram, 
Indonesia) death adders are found in PNG, with A. laevis also being found on the 
surrounding Indonesian islands. Although, in the past, the venom samples collected 
from Seram specimens have been referred to as A. sp. Seram, it has been reported that 
A. sp. Seram belongs to the A. laevis complex (Wüster et al., 2005). This study will 
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therefore refer to A. sp. Seram as A. laevis. For each geographic variant or major 
species, venoms were collected and pooled to minimize the effects of individual 
variations (Chippaux et al., 1991). Venoms were collected from fang tips through the 
specimen biting down on a parafilm covered specimen bottle and injecting the venom 
into a polyethylene container, in combination with the use of polyethylene pipette tip to 
milk any residual venom from the fang. The venoms were then lyophilised and stored at 
–20°C until required.  
 
2.2. Size-exclusion FPLC under non-denaturing conditions 
Bioassay-guided isolation of toxins from whole venom was performed using a Shimadzu 
CLASS-VP HPLC system. Prior to separation, samples were suspended in equilibration 
buffer and centrifuged at 10,000 rpm for 5 min, with the resulting supernatant 
(equivalent to ca. 3 mg of venom) applied to a Superdex G-75 column (10 x 300 mm, 13 
µm; GE Healthcare, Sydney, NSW, Australia) equilibrated with ammonium acetate (0.1 
M, pH 6.8). Fractions were eluted using an isocratic gradient at a flow rate of 0.75 
ml/min. Elution profiles were monitored at 280 and 214 nm, however only the profile 
obtained at 280 nm is shown. Resulting fractions were screened for both neurotoxic and 
myotoxic activity using the chick biventer cervicis nerve-muscle (CBCNM) preparation 
(see section 2.4) and phospholipase A2 (PLA2) activity (see section 2.5). The 
approximate molecular mass of any SPAN complex was determined by gel filtration 
under non-reducing conditions on the Superdex G-75 column equilibrated with 
ammonium acetate buffer (0.1 M; pH 6.8). The column was calibrated with the series of 
known standards (6.5–66 kDa) using the molecular mass marker kit for gel filtration 
chromatography (lot no. 093K9307; MWGF-70; Sigma-Aldrich, St. Louis, MO) at a flow 
rate of 0.75 ml/min. The void volume (Vo) of the column was determined by running blue 
dextran (2,000 kDa), and the elution volume (Ve) was calculated for each molecular 
mass marker. The molecular mass range of SPAN complexes were then determined 
from interpolation of a plot of log molecular mass versus retention ratio (Ve / Vo) of the 
standards. 
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2.3 Bicinchoninic Acid Protein (BCA) Assay: 
Following lyophilisation, the protein concentrations of purified high molecular mass 
fractions were determined using the Quantipro™ BCA assay kit (Sigma-Aldrich). Protein 
contents between 5–200 µg/ml were detected at 560 nm by a Titertek Multiscan Plus 
MKII (type 313) plate reader (Flow Laboratories Australasia, North Ryde, NSW). A 
standard curve was created using bovine serum albumin from which protein 
concentrations of the venom fractions were interpolated. Yields of the high molecular 
mass fraction (22 to >66 kDa) were then expressed as a percentage of whole venom 
loaded onto the column (3 mg). 
 
2.4. Isolated chick biventer cervicis nerve-muscle preparation 
Isolated fractions were tested for neurotoxic and myotoxic activity using the isolated 
CBCNM preparation (Ginsborg and Warriner, 1960). Male Australorps chicks aged 1–7 
days were euthanised with CO2 and exsanguinated. The biventer cervicis muscle with 
attached nerve was dissected and placed in an organ bath (5 or 8 ml) under 1 gram of 
resting tension. The organ bath contained Krebs–Henseleit solution of the following 
composition (in mM): NaCl, 118.4; KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 25.0; 
D-glucose, 11.1; CaCl2, 2.5, which was bubbled with carbogen (95% O2 and 5% CO2) 
and maintained at 34°C. Indirect stimulation was applied to the motor nerve using 
supramaximal 30 V square-wave pulses of 0.2 ms duration at 0.1 Hz with a Grass S88 
stimulator. Contractions were measured using an isometric force transducer 
(ADInstruments, Belle Vista, NSW, Australia). The nerve-muscle preparation was 
allowed to equilibrate for 30 minutes. Exclusive electrical stimulation of the nerve was 
confirmed by complete blockade of twitches using 10 µM d-tubocurarine. Washout was 
then repeated until twitch tension returned to its original amplitude. Contractures to 
various exogenous agonists were subsequently recorded in the absence of electrical 
stimulation before, and after, incubation with the SPAN. The final bath concentrations 
and periods of incubation for each exogenous agonist were as follows: acetylcholine 
(ACh, 1 mM) for 30 s; carbachol (CCh, 20 µM) for 60 s; potassium chloride (KCl, 40 
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mM) for 30 s (Harvey et al., 1994). After each agonist incubation period, washout was 
repeated until a stable baseline was observed. Following addition of SPAN (10 µg/ml), 
twitch tension amplitude was monitored for 4 hours, or until twitches were abolished. 
Time-matched controls confirmed that muscle fatigue was not significant up to 4 hours 
after introduction of muscles into the organ bath. Muscle tension from isometric force 
transducers was amplified using a ML221 bridge amplifier (ADInstruments) and 
recorded using a Powerlab 2/25 system (ADInstruments) connected to an iMac or PC 
computer. Data was digitised at 140 Hz and filtered using 50/60 Hz high-pass and 20–
200 Hz low-pass filters. Muscle tension was recorded using Chart v5.5.4 software 
(ADInstruments).  
 
2.5. Phospholipase A2 (PLA2) activity assay 
The PLA2 activity of whole venoms and isolated toxins were determined using a 
colorimetric sPLA2 assay kit (Cayman Chemical Ltd, Ann Arbor, MI, USA). The 
presence of a PLA2 enzyme catalyses the hydrolysis of the thio ester bond on the 
phospholipid substrate (1,2-dithio analog of diheptanoyl phosphohatidylcholine) at the 
sn-2 position. This results in the production of free thiols which are detected by 5,5’-
dithio-bis-(2-nitrobenzoic acid). Colour development was monitored using a BIO-RAD 
model 3550-UV microplate reader at 405 nm. Measurements were made every 20 s for 
5 min. PLA2 activity was calculated as micromoles of substrate hydrolysed per minute 
per milligram of enzyme (µmol/min/mg), with bee (Apis mellifera) venom as a positive 
control. 
 
2.6. Mass spectrometry 
MALDI-TOF mass spectrometry was performed on a Voyager DE-Pro instrument 
(Applied Biosystems, Foster City, CA, USA) operated in positive linear mode. Crude 
venom samples were dissolved in 10 ml HPLC-grade water and 0.5 ml samples were 
mixed on-plate in a 1:2 ratio with 3,5 dimethoxy-4-hydroxycinnamic acid (sinapinic acid) 
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matrix made up in acetonitrile/water/trifluoroacetic acid (30:70:0.1). Spectra were 
externally calibrated with a mixture of synthetic proteins (5,700–17,000 Da mass range, 
LaserBio Labs, France) using the same matrix system. Spectra were processed using 
the Data Explorer software package (Applied Biosystems). 
 
2.6. Chemicals and drugs 
Unless otherwise stated, all chemicals and drugs were purchased from Sigma-Aldrich, 
Castle Hill, NSW, Australia. 
 
2.7. Data analysis 
Twitch contraction amplitude was expressed as a percentage of initial amplitude, prior 
to addition of the SPAN. Contractile responses to exogenous agonists were expressed 
as a percentage of their amplitude prior to addition of the SPAN. To compare the 
neurotoxicity of venoms, the time taken to cause 90% inhibition of nerve-mediated 
twitch contractions (t90) was determined as a quantitative measure of potency. Values 
for t90 were calculated for each experiment by determining the elapsed time, after 
venom addition, to 10% of the initial twitch amplitude, and then the means and standard 
error of the means were calculated. Where indicated, statistical significance was 
determined by one-way analysis of variance (ANOVA) or paired Student’s t-test. All 
ANOVAs were followed by a Bonferroni-corrected multiple t-test. Statistical analyses 
were performed using the PRISM 4.0 software package (GraphPad Software, San 
Diego, CA, USA). A p-value of 0.05 was employed for all statistical analyses. 
 
3. Results 
3.1. Venom fractionation 
Separation of Acanthophis spp. whole venoms by size-exclusion FPLC under non-
reducing conditions produced a characteristic pattern of fractions from all death adder 
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venom samples (Fig. 1). In general, resultant chromatograms displayed 4–6 major 
peaks. Nevertheless, variation in chromatographic profiles was evident between the 
regional variants of A. antarcticus as well as other Acanthophis spp., where the variation 
was more pronounced. Given that SPAN complexes have molecular masss ranging 
between 21 kDa (the covalently-linked heterodimer β-bungarotoxin from Bungarus 
fasciatus; (Chu et al., 1995) and ca. 87 kDa (the heterohexameric textilotoxin; (Aquilina, 
2009) fractions falling into this molecular mass range were collected for neurotoxicity 
testing. Following calibration of the size-exclusion column using a set of molecular mass 
markers, the retention times of early-eluting fractions were found to be consistent with a 
molecular mass range between 22 kDa to >66 kDa (shaded fractions in Fig. 1Aa and B). 
Given that the calibration of the size-exclusion Sephadex G-75 column may not be 
linear beyond 66 kDa (bovine serum albumin was the highest mass standard used), we 
have elected not to extrapolate beyond this upper limit. Importantly, separation of A. 
wellsi and A. pyrrhus venoms did not result in any early-eluting components (Fig. 1Ab) 
and therefore these venoms were not investigated any further in this study. For the 
remaining venoms, the yields of this high molecular mass fraction, as determined by the 
BCA assay, appear to vary significantly, with A. laevis possessing the highest yield of 
14.9% w/w while A. antarcticus (SA) had the lowest yield of 2.7% w/w. The percent 
yields of the prejunctional neurotoxin component from each Acanthophis venom are 
shown in Table 1. 
 
3.2. Neurotoxicity studies 
Apart from A. antarcticus (SA) venom, all high molecular mass fractions produced time-
dependant inhibition of nerve-evoked twitch contractions within 240 min (n = 3–4; Fig. 
2A), whereas with time-matched controls there was no significant inhibition of twitch 
tension over the 240 min period (Fig. 2B). The mean t90 values ranged from 59 to 85 
min (see Table 1). There was no significant difference between high molecular mass 
fractions from all venoms except that from A. antarcticus (SA) venom, which failed to 
reach 90% block after 240 min. Because experiments were terminated after 240 min, 
the t90 value for the high molecular mass fraction from A. antarcticus (SA) venom was 
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not determined. A triphasic timecourse of action characterized by depression-
enhancement-blockade of neurotransmission was evident with the high molecular mass 
fraction from the WA and NSW geographic variants of A. antarcticus as has been 
previously reported for a variety of other SPANs in mammalian nerve-muscle 
preparations (Su and Chang, 1984; Wilson et al., 1995). The remaining Acanthophis 
spp. venom fractions did not overtly display this triphasic timecourse, consistent with 
that often seen for SPANs in avian neuromuscular preparations (Beghini et al., 2004; 
Kuruppu et al., 2005b). 
Importantly, following complete neuromuscular blockade by all high molecular mass 
fractions, responses to cholinergic agonists were still present whereas the negative 
control had no significant inhibitory effect on the contractures produced by exogenous 
agonists (n = 3–4; Fig. 3). While A. laevis caused the only statistically significant 
inhibition of ACh responses (one-way ANOVA, p < 0.01, n = 3), contractures were not 
completely abolished. Moreover, the responses to carbachol were not significantly 
inhibited by any high molecular mass fraction (one-way ANOVA, p > 0.05, n = 3–4). 
Interestingly, the responses to carbachol were enhanced in controls and venom 
fractions but this has been previously reported in this preparation (Kuruppu et al., 
2005a; Kuruppu et al., 2005b; Lumsden et al., 2005) and may reflect time-dependent 
sensitization of the tissue to carbachol. All fractions failed to significantly inhibit 
responses to potassium chloride (one-way ANOVA, p > 0.05, n = 3–4) and did not 
cause a significant change in the baseline tension of the biventer cervicis muscle (data 
not shown). These actions are consistent with the presence of SPAN complexes in the 
high molecular mass fraction that inhibit neurotransmitter release.  
 
3.3. PLA2 activity 
The PLA2 activity of whole venoms and isolated prejunctional neurotoxic components 
showed some variability (Fig. 3). Whole venoms and isolated components all possessed 
PLA2 activity, however the individual activities were much lower than the positive control 
(bee venom), which had a PLA2 activity of 181.8 ± 9.7 µmol/min/mg. PLA2 activity of the 
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weakly-active A. antarcticus (SA) component possessed the lowest enzymatic activity, 




3.4 Mass spectrometry 
Given that there was considerable variation in the neurotoxicity of the regional variants 
of A. antarcticus, the mass profile of NSW, QLD and SA geographic variants of A. 
antarcticus venoms were examined. The MALDI-TOF mass spectra of these venoms 
were dominated by high-intensity ions at ca. 6400–6700, 6700–7100, 7200–8900 and 
12800–14000 m/z ranges (Fig. 5). This is consistent with the presence of Kunitz-type 
protease inhibitors, short-chain α-neurotoxins, long-chain α-neurotoxins and monomeric 
PLA2 neurotoxins, respectively. Allowing for minor measurement differences resulting 
from external calibration, it appears that these venoms contain a number of equivalent 
PLA2 components particular at ca. m/z 12847, 12901, 13461, 13816, and 13916, 
although the molecular identity of these proteins would need to be confirmed via Edman 
sequencing. Two of these masses are similar to those previously determined for the 
monomeric PLA2 proteins acanthoxin A1 (12842 Da) and acanthoxin A2 (12896 Da) 
(van der Weyden et al., 1997) as well as the platelet aggregation inhibitors acanthin I 
(12845 Da) and acanthin II (12,896 Da) (Chow et al., 1998) from A. antarcticus venom 
(unnamed variants). Furthermore, the venoms also contained a number of conserved 
masses ca. m/z 6711, 6752, 6860, consistent with short-chain α-neurotoxins and m/z 
8185 and 8856, consistent with long-chain α-neurotoxins (see highlighted masses in 
Fig. 5). An additional mass at m/z 6653, present in all three venoms, is consistent with a 
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Excluding the venoms of A. wellsi and A. pyrrhus, all species including the geographic 
variants of death adder venoms contained early eluting fractions with masses estimated 
between 22 and >66 kDa. Apart from A. antarcticus (SA), each of these high molecular 
mass fractions caused a block of muscle contractility consistent with strong 
prejunctional neurotoxicity. Each of these components also possessed significant PLA2 
enzymatic activity. Given that these components represent a significant portion of the 
whole venom, they would therefore contribute to the overall toxicity of the venom. The 
estimated size, neurotoxicity and PLA2 enzymatic activity indicates that these isolated 
venom components most likely contain SPANs that are likely composed of a multimeric 
structure. It is interesting to speculate therefore that these SPANs have a similar 
heterotrimeric complex of ca. 45 kDa much like previously isolated SPANs such as 
taipoxin, cannitoxin and paradoxin from various species of Oxyuranus (Fohlman, 1979; 
Fohlman et al., 1976; Kuruppu et al., 2005b). A number of components with molecular 
masses comparable to other snake monomeric PLA2 neurotoxins and inhibitors of 
platelet aggregation (ca. 12.8–14 kDa) were conserved in venoms from NSW, QLD and 
SA geographic variants of A. antarcticus. It is therefore surprising that A. antarcticus 
(SA) venom, which possessed only a weakly active high molecular mass fraction, 
contained all five of these proteins. This suggests that other components in this mass 
range form the subunits of the SPAN complex. While there exists the possibility that this 
fraction could contain blockers of voltage-gated sodium or calcium channels to inhibit 
neurotransmission, the high mass and PLA2 activity consistent with other SPANs would 
argue against this. Further biochemical studies of several of these venoms is presently 
being undertaken to ascertain the subunit structure and confirm the pharmacological 
basis for this prejunctional neurotoxicity (unpublished data). 
Of note is the absence of a high molecular mass SPAN complex in the venoms of A. 
wellsi and A. pyrrhus. These two well-differentiated species are believed to belong to a 
separate clade distinct from other species of Acanthophis (Wüster et al., 2005), 
supporting their unique size-exclusion chromatographic profile. Importantly, these two 
venoms appear to have a higher yield of monomeric PLA2 neurotoxins (ca. 12.8–14 
kDa) and/or postsynaptic α-neurotoxins (ca. 6.7–8.9 kDa) based on the molecular mass 
of the large eluting peak between 17 and 22 min (Fig. 1Ab).  
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Notably there was an apparent lack of any overt myotoxicity in the high molecular mass 
fraction of all venoms, as evidenced by a lack of inhibition of KCl responses and the 
absence of any change in baseline tension in the CBCNM preparation. This would 
suggest that previously identified myotoxins from A. rugosus (Wickramaratna et al., 
2003a) and A. sp. Seram (A. laevis in this study; (Hart et al., 2005) appear to exist as 
monomeric PLA2 myotoxins (13082–13896 Da), eluting later in the size-exclusion 
chromatogram rather than as a complex of higher molecular mass. Thus none of the 
high molecular mass SPAN complexes in Acanthophis venoms appear to possess 
significant myotoxic activity, as has been described for the 45 kDa heterotrimeric SPAN, 
taipoxin (Harris et al., 2000; Harris and Maltin, 1982). 
The poor reversibility of Acanthophis neurotoxicity particularly A. antarcticus, both in 
vitro (Wickramaratna and Hodgson, 2001) and clinically (Gunja et al., 2007), could be 
the result of irreversible binding of long-chain snake α-neurotoxins. In support, long-
chain snake α-neurotoxins such as Aa b (8125 Da, (Kim and Tamiya, 1981), Aa e (8751 
Da, (Tyler et al., 1997), acanthophin d (8377 Da, (Sheumack et al., 1990), and α-
elapitoxin-Aa2a (8850 Da, Blacklow B and Nicholson GM, unpublished observations) 
have been identified in the venom of various geographic variants of A. antarcticus. They 
appear to bind with high affinity and are poorly reversible (Sheumack et al., 1990); 
Blacklow B and Nicholson GM, unpublished observations). In the present study, several 
polypeptides in a mass range consistent with the presence of long-chain α-neurotoxins 
(ca. 7.2–8.9 kDa) were also confirmed in the venoms of NSW, QLD and SA geographic 
variants. It is important to note, however, that the toxicity and reversibility of all 
Acanthophis long-chain α-neurotoxins, except acanthophin d and α-elapitoxin-Aa2a, is 
assumed based on size of toxin and symptoms arising from parenteral administration in 
mice. Furthermore, none of masses of the previously reported long-chain α-neurotoxins 
were identified in the MALDI-TOF mass profiles in Figure 5. In summary, the present 
study has identified the presence of SPANs in at least six, of the nine, venoms 
investigated. If long-chain snake α-neurotoxins were also present in any of these other 
venoms they should only serve to increase the poor reversibility of neurotoxicity seen 
with inadequate use of antivenom. 
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Reduction in the ACh response by the high molecular mass fraction of A. laevis venom 
could be due to the presence of postsynaptic PLA2 complexes such as has been 
described for vipoxin a 27.5 kDa heterodimeric PLA2 complex from the Bulgarian viper 
(Vipera ammodytes meridionalis) (Banumathi et al., 2001). On the hand, the reduction 
in ACh response could also be due to the presence of an acetylcholinesterase in the 
high molecular mass fraction in amounts sufficient to hydrolyse exogenous 
acetylcholine. Acetylcholinesterase has been characterized previously from Bungarus 
fasciatus venom (Cousin et al., 1996) and matched to several 70-kDa proteins in the 
venoms of several Australian elapids, including A. antarcticus, in a recent proteomic 
study (Birrell et al., 2007). However, neither of these possibilities is likely given that 
responses to carbachol, a nicotinic agonist resistant to the actions of 
acetylcholinesterase, were not significantly inhibited at complete neuromuscular 
blockade.  
The effectiveness of prior administration of antivenom (5 U/ml) to completely neutralize 
the in vitro neurotoxicity of venom from all major species and geographic variants of 
Acanthophis has been previously confirmed (Fry et al., 2001). Therefore, considering 
the present findings that the majority of death adder venoms contain SPANs, early 
intervention with antivenom is critically important in preventing severe prolonged 
envenomation. The results of the present study indicate that clinicians may need to be 
aware of possible prejunctional neurotoxicity following envenomation from A. antarcticus 
(all geographic variants except SA), A. praelongus, A. rugosus, or A. laevis species. 
Unfortunately, there are no current treatments that prevent the destruction of the nerve 
terminal once the process of degeneration has been initiated, enhance the repair of the 
structural damage to the peripheral innervation or increase the rate at which the victims 
recover neuromuscular function. This would suggest that early antivenom intervention is 
essential to preventing the further development of toxicity caused by these snakes. 
 
Acknowledgements 
B. Blacklow et al. / Toxicon 
	  
18	  
This work was supported in part by an Australian Postgraduate Award to BB. The 
authors wish to thank Dr Pierre Escoubas, Université de Nice – Sophia Antipolis, IPMC, 
CNRS, Valbonne, France who carried out the MALDI-TOF mass spectrometry. 
References 
 
Aquilina, J.A., 2009. The major toxin from the Australian Common Brown Snake is a 
hexamer with unusual gas-phase dissociation properties. Proteins 75, 478-485. 
Banumathi, S., Rajashankar, K.R., Nötzel, C., Aleksiev, B., Singh, T.P., Genov, N., 
Betzel, C., 2001. Structure of the neurotoxic complex vipoxin at 1.4 Å resolution. 
Acta Crystallogr. D Biol. Crystallogr. 57, 1552-1559. 
Beghini, D.G., Rodrigues-Simioni, L., Toyama, M.H., Novello, J.C., da Cruz-Höfling, 
M.A., Marangoni, S., 2004. Neurotoxic and myotoxic actions of crotoxin-like and 
Crotalus durissus cascavella whole venom in the chick biventer cervicis preparation. 
Toxicon 43, 255-261. 
Birrell, G.W., Earl, S.T.H., Wallis, T.P., Masci, P.P., de Jersey, J., Gorman, J.J., Lavin, 
M.F., 2007. The diversity of bioactive proteins in Australian snake venoms. Mol. 
Cell. Proteomics 6, 973-986. 
Campbell, C.H., 1966. The death adder (Acanthophis antarcticus): the effect of the bite 
and its treatment. Med. J. Aust. 2, 922-925. 
Chippaux, J.P., Williams, V., White, J., 1991. Snake venom variability: methods of 
study, results and interpretation. Toxicon 29, 1279-1303. 
Chow, G., Subburaju, S., Kini, R.M., 1998. Purification, characterization, and amino acid 
sequence determination of acanthins, potent inhibitors of platelet aggregation from 
Acanthophis antarcticus (common death adder) venom. Arch. Biochem. Biophys. 
354, 232-238. 
Chu, C.C., Li, S.H., Chen, Y.H., 1995. Resolution of isotoxins in the β-bungarotoxin 
family. J. Chromat. A 694, 492-497. 
Connolly, S., Trevett, A.J., Nwokolo, N.C., Lalloo, D.G., Naraqi, S., Mantle, D., 
Schofield, I.S., Fawcett, P.R., Harris, J.B., Warrell, D.A., 1995. Neuromuscular 
effects of Papuan Taipan snake venom. Ann. Neurol. 38, 916-920. 
B. Blacklow et al. / Toxicon 
	  
19	  
Cousin, X., Bon, S., Duval, N., Massoulié, J., Bon, C., 1996. Cloning and expression of 
acetylcholinesterase from Bungarus fasciatus venom. A new type of COOH-terminal 
domain; involvement of a positively charged residue in the peripheral site. J. Biol. 
Chem. 271, 15099-15108. 
Cull-Candy, S.G., Fohlman, J., Gustavsson, D., Lullmann-Rauch, R., Thesleff, S., 1976. 
The effects of taipoxin and notexin on the function and fine structure of the murine 
neuromuscular junction. Neuroscience 1, 175-180. 
Currie, B.J., 1989. Urban envenomation (Letter). Med. J. Aust. 151, 724. 
Currie, B.J., 2003. Snakebite in Australia: moving from anecdotes to prospective 
studies. Emerg. Med. (Fremantle, WA) 15, 406-408. 
Currie, B.J., 2006. Treatment of snakebite in Australia: the current evidence base and 
questions requiring collaborative multicentre prospective studies. Toxicon 48, 941-
956. 
Dixon, R.W., Harris, J.B., 1999. Nerve terminal damage by β-bungarotoxin: its clinical 
significance. Am. J. Pathol. 154, 447-455. 
Fohlman, J., 1979. Comparison of two highly toxic Australian snake venoms: the taipan 
(Oxyuranus s. scutellatus) and the fierce snake (Parademansia microlepidotus). 
Toxicon 17, 170-172. 
Fohlman, J., Eaker, D., Karlsoon, E., Thesleff, S., 1976. Taipoxin, an extremely potent 
presynaptic neurotoxin from the venom of the Australian snake taipan (Oxyuranus 
s. scutellatus). Isolation, characterization, quaternary structure and pharmacological 
properties. Eur. J. Biochem. 68, 457-469. 
Fry, B.G., Wickramaratna, J.C., Hodgson, W.C., Alewood, P.F., Kini, R.M., Ho, H., 
Wüster, W., 2002. Electrospray liquid chromatography/mass spectrometry 
fingerprinting of Acanthophis (death adder) venoms: taxonomic and toxinological 
implications. Rapid Commun Mass Spectrom 16, 600-608. 
Fry, B.G., Wickramaratna, J.C., Jones, A., Alewood, P.F., Hodgson, W.C., 2001. 
Species and regional variations in the effectiveness of antivenom against the in vitro 
neurotoxicity of death adder (Acanthophis) venoms. Toxicol. Appl. Pharmacol. 175, 
140-148. 
B. Blacklow et al. / Toxicon 
	  
20	  
Ginsborg, B.L., Warriner, J., 1960. The isolated chick biventer cervicis nerve-muscle 
preparation. Brit. J. Pharmacol. 15, 410-411. 
Gunja, N., Ling, M.L., Dowsett, R.P., Murray, L., Isbister, G.K., 2007. Antivenom and 
neostigmine failure in death adder envenoming. Clin. Toxicol. 45, 389. 
Harris, J.B., Grubb, B.D., Maltin, C.A., Dixon, R., 2000. The neurotoxicity of the venom 
phospholipases A2, notexin and taipoxin. Exp. Neurol. 161, 517-526. 
Harris, J.B., Maltin, C.A., 1982. Myotoxic activity of the crude venom and the principal 
neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus. Br. J. 
Pharmacol. 76, 61-75. 
Hart, A.J., Smith, A.I., Reeve, S., Hodgson, W.C., 2005. Isolation and characterisation 
of acanmyotoxin-2 and acanmyotoxin-3, myotoxins from the venom of the death 
adder Acanthophis sp. Seram. Biochem. Pharmacol. 70, 1807-1813. 
Harvey, A.L., Barfaraz, A., Thomson, E., Faiz, A., Preston, S., Harris, J.B., 1994. 
Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro 
preparations from rodents and chicks. Toxicon 32, 257-265. 
Hodgson, W.C., Dal Belo, C.A., Rowan, E.G., 2007. The neuromuscular activity of 
paradoxin: a presynaptic neurotoxin from the venom of the inland taipan 
(Oxyuranus microlepidotus). Neuropharmacology 52, 1229-1236. 
Hudson, B.J., Pomat, K., 1988. Ten years of snake bite in Madang Province, Papua 
New Guinea. Trans. R. Soc. Trop. Med. Hyg. 82, 506-508. 
Kelly, R.B., Brown, F.R., 1974. Biochemical and physiological properties of a purified 
snake venom neurotoxin which acts presynaptically. J. Neurobiol. 5, 135-150. 
Kim, H.S., Tamiya, N., 1981. Isolation, properties and amino acid sequence of a long-
chain neurotoxin, Acanthophis antarcticus b, from the venom of an Australian snake 
(the common death adder, Acanthophis antarcticus). Biochem. J. 193, 899-906. 
Kuruppu, S., Fry, B.G., Hodgson, W.C., 2005a. Presynaptic neuromuscular activity of 
venom from the brown-headed snake (Furina tristis). Toxicon 45, 383-388. 
Kuruppu, S., Reeve, S., Banerjee, Y., Kini, R.M., Smith, A.I., Hodgson, W.C., 2005b. 
Isolation and pharmacological characterization of cannitoxin, a presynaptic 
neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni). J. 
Pharmacol. Exp. Ther. 315, 1196-1202. 
B. Blacklow et al. / Toxicon 
	  
21	  
Lalloo, D.G., Trevett, A.J., Black, J.A., Mapao, J., Naraqi, S., Owens, D., Hutton, R.A., 
Theakston, R.D., Warrell, D.A., 1994. Neurotoxicity and haemostatic disturbances in 
patients envenomed by the Papuan black snake (Pseudechis papuanus). Toxicon 
32, 927-936. 
Lalloo, D.G., Trevett, A.J., Black, J.A., Mapao, J., Saweri, A., Naraqi, S., Owens, D., 
Kamiguti, A.S., Hutton, R.A., Theakston, R.D., Warrell, D.A., 1996. Neurotoxicity, 
anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death 
adders (Acanthophis sp.) in southern Papua New Guinea. QJM 89, 25-35. 
Lumsden, N.G., Fry, B.G., Ventura, S., Kini, R.M., Hodgson, W.C., 2005. 
Pharmacological characterisation of a neurotoxin from the venom of Boiga 
dendrophila (mangrove catsnake). Toxicon 45, 329-334. 
Pearn, J.H., 1971. Survival after snake-bite with prolonged neurotoxic envenomation. 
Med. J. Aust. 2, 259-261. 
Rossetto, O., Montecucco, C., 2008. Presynaptic neurotoxins with enzymatic activities. 
Handb. Exp. Pharmacol., 129-170. 
Sanders, K.L., Lee, M.S.Y., Leys, R., Foster, R., Keogh, J.S., 2008. Molecular 
phylogeny and divergence dates for Australasian elapids and sea snakes 
(hydrophiinae): evidence from seven genes for rapid evolutionary radiations. J. 
Evol. Biol. 21, 682-695. 
Sheumack, D.D., Spence, I., Tyler, M.I., Howden, M.E.H., 1990. The complete amino 
acid sequence of a post-synaptic neurotoxin isolated from the venom of the 
Australian death adder snake Acanthophis antarcticus. Comp. Biochem. Physiol. B 
95, 45-50. 
Sim, K., 1998. Purification and preliminary characterisation of praelongin 
phospholipases, antiplatelet agents from the snake venom of Acanthophis 
praelongus. Biochim. Biophys. Acta 1379, 198-206. 
Su, M.J., Chang, C.C., 1984. Presynaptic effects of snake venom toxins which have 
phospholipase A2 activity (β-bungarotoxin, taipoxin, crotoxin). Toxicon 22, 631-640. 
Su, M.J., Coulter, A.R., Sutherland, S.K., Chang, C.C., 1983. The presynaptic 
neuromuscular blocking effect and phospholipase A2 activity of textilotoxin, a potent 
B. Blacklow et al. / Toxicon 
	  
22	  
toxin isolated from the venom of the Australian brown snake, Pseudonaja textilis. 
Toxicon 21, 143-151. 
Trevett, A.J., Lalloo, D.G., Nwokolo, N.C., Naraqi, S., Kevau, I.H., Theakston, R.D., 
Warrell, D.A., 1995. The efficacy of antivenom in the treatment of bites by the 
Papuan taipan (Oxyuranus scutellatus canni). Trans. R. Soc. Trop. Med. Hyg. 89, 
322-325. 
Tyler, M.I., Retson-Yip, K.V., Gibson, M.K., Barnett, D., Howe, E., Stöcklin, R., Turnbull, 
R.K., Kuchel, T., Mirtschin, P., 1997. Isolation and amino acid sequence of a new 
long-chain neurotoxin with two chromatographic isoforms (Aa el and Ae e2) from 
the venom of the Australian death adder (Acanthophis antarcticus). Toxicon 35, 
555-562. 
van der Weyden, L., Hains, P., Broady, K.W., 2000. Characterisation of the biochemical 
and biological variations from the venom of the death adder species (Acanthophis 
antarcticus, A. praelongus and A. pyrrhus). Toxicon 38, 1703-1713. 
van der Weyden, L., Hains, P., Morris, M., Broady, K.W., 1997. Acanthoxin, a toxic 
phospholipase A2 from the venom of the common death adder (Acanthophis 
antarcticus). Toxicon 35, 1315-1325. 
White, J., 1998. Envenoming and antivenom use in Australia. Toxicon 36, 1483-1492. 
White, J., 2001. CSL Antivenom Handbook. CSL Ltd., Melbourne. 
Wickramaratna, J.C., Fry, B.G., Aguilar, M.I., Kini, R.M., Hodgson, W.C., 2003a. 
Isolation and pharmacological characterization of a phospholipase A2 myotoxin from 
the venom of the Irian Jayan death adder (Acanthophis rugosus). Br. J. Pharmacol. 
138, 333-342. 
Wickramaratna, J.C., Fry, B.G., Hodgson, W.C., 2003b. Species-dependent variations 
in the in vitro myotoxicity of death adder (Acanthophis) venoms. Toxicol. Sci. 74, 
352-360. 
Wickramaratna, J.C., Hodgson, W.C., 2001. A pharmacological examination of venoms 
from three species of death adder (Acanthophis antarcticus, Acanthophis 
praelongus and Acanthophis pyrrhus). Toxicon 39, 209-216. 
B. Blacklow et al. / Toxicon 
	  
23	  
Williams, D., Wuster, W., Fry, B.G., 2006. The good, the bad and the ugly: Australian 
snake taxonomists and a history of the taxonomy of Australia's venomous snakes. 
Toxicon. 
Wilson, H.I., Nicholson, G.M., Tyler, M.I., Howden, M.E.H., 1995. Induction of giant 
miniature end-plate potentials during blockade of neuromuscular transmission by 
textilotoxin. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 79-87. 
Wüster, W., Dumbrell, A., Hay, C., Pook, C., Williams, D., Fry, B., 2005. Snakes across 
the Strait: trans-Torresian phylogeographic relationships in three genera of 
Australasian snakes (Serpentes: Elapidae: Acanthophis, Oxyuranus, and 
Pseudechis). Mol. Phylogen. Evol. 34, 1-14. 
Wüster, W., Golay, P., Warrell, D.A., 1999. Synopsis of recent developments in 
venomous snake systematics, No. 3. Toxicon 37, 1123-1129. 
 
 
Conflict of interest statements: 
The authors declare that there are no conflicts of interest 
 
  














A. antarcticus (NSW) 24 – >66 6.5 77 ± 3 4 
A. antarcticus (QLD) 34 – >66 12.6 63 ± 3 3 
A. antarcticus (WA) 32 – >66 6.3 59 ± 5 3 
A. antarcticus (SA) 24 – >66 2.7 > 240 3 
A. praelongus 37 – >66 5.2 70 ± 2 3 
A. rugosus 22  –  52 5.6 85 ± 3 3 
A. laevis 22  –  52 14.9 73 ± 3 3 
A. wellsi Not found – – 2 
A. pyrrhus Not found – – 2 
 
* t90 values represent the mean ± SEM 





Fig. 1: Representative size-exclusion FPLC chromatograms from Australian (A) and 
Papuan (B) Acanthophis spp. venoms employing a Superdex G-75 column with an 
isocratic flow of 0.1 M ammonium acetate (pH 6.8) at 0.75 ml/min. Shaded fractions on 
each chromatogram, corresponding to high molecular mass fractions (22 to >66 kDa), 
were collected for further analysis. (Ab) The shaded panel shows chromatograms of A. 
wellsi and A. pyrrhus venoms that lack high molecular mass fractions. 




Fig. 2: Inhibition of indirectly-stimulated fast twitch contractions by high molecular mass 
fractions from Acanthophis spp. venoms in the isolated chick biventer cervicis nerve-
muscle preparation. (A) Geographic variants of A. antarcticus. (B) Remaining 
Acanthophis species and time-matched (negative) control. All fractions were tested at 
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10 µg/ml and data represents the mean ± SEM of 4 experiments for A. antarcticus 
(NSW) or 3 experiments for all other venom fractions and negative control. 
 
Fig. 3: Effect of high molecular mass fractions from Acanthophis spp. venoms on 
contractile responses to exogenous ACh, CCh and KCl in the isolated chick biventer 
cervicis nerve-muscle preparation. Data shows the percentage of control slow fibre 
contracture responses to exogenous agonists after complete inhibition of nerve-evoked 
twitch contractions by all high molecular mass fractions. In the case of A. antarcticus 
(SA), data were recorded at 280 min. All fractions were tested at 10 µg/ml and data 
represents the mean ± SEM of 4 experiments for A. antarcticus (NSW) or 3 experiments 
for all other venom fractions. *p < 0.01, significantly different from control response, 
one-way ANOVA. 
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Fig. 4: PLA2 activity of whole Acanthophis spp. venoms (left-hand columns) and their 
high molecular mass fraction (right-hand columns) as determined using the sPLA2 
assay kit. Whole venoms from A. wellsi and A. pyrrhus were omitted as they did not 
contain an early eluting peak for toxicity testing. Bee (Apis mellifera) venom was used 
as a positive control. 
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Fig. 5: MALDI-TOF mass spectra of venom from A. antarcticus geographic variants. 
Spectra are focused on masses (m/z) consistent with the presence of short-chain α-
neurotoxins (‘Short’, light grey), long-chain α-neurotoxins (‘Long’, dark grey) and 
monomeric PLA2 neurotoxins (‘PLA2’, black). Major peaks are labeled while a complete 
mass list is shown to the right of each panel. Masses common to at least two venoms 
are highlighted. 
